Pediatric Neuroblastoma Treatment Market - High Incidence of Neuroblastoma to Drive the Demand
Added: (Fri Jan 25 2019)
Pressbox (Press Release) -
The global pediatric neuroblastoma treatment market is projected to reach US$ 1.3 Bn by 2026, expanding at a high CAGR during the forecast period. Rise in R&D expenditure, increase in incidence of neuroblastoma among children, and rise in awareness about available treatments are the factors anticipated to augment the global market during the forecast period. Moreover, advancement in technology and improvement in health care infrastructure are expected to propel the global pediatric neuroblastoma treatment market during the forecast period. However, high research and development cost associated with cancer therapy is likely to hamper the growth of the market.
Read Report Overview: https://www.transparencymarketresearch.com/pediatric-neuroblastoma-treatment-market.html
The global pediatric neuroblastoma treatment market has been segmented based on therapy type and distribution channel. In terms of therapy type, the market has been classified into immunotherapy, chemotherapy, and others. The chemotherapy segment held leading market share in 2017. The segment is projected to expand at the highest CAGR during the forecast period. This is attributed to effectiveness of chemotherapy drugs in neuroblastoma treatment. Moreover, chemotherapy is the treatment of choice to slow down disease progression and reduce symptoms. It can also be combined with other treatments such as radiation therapy or surgery for more effective results.
Based on distribution channel, the global pediatric neuroblastoma treatment market has been categorized into hospital pharmacies and retail pharmacies & drug stores. The hospital pharmacies segment dominated the market in 2017 and is expected to retain its leadership position in terms of market share during the forecast period. This is due to high preference to hospital pharmacies for purchasing drugs prescribed for cancer treatment. Moreover, hospital pharmacies ensure drug safety and accurate dosage of drugs as per treatment prescription.
In terms of region, the global pediatric neuroblastoma treatment market has been segmented into North America, Europe, and Rest of the World. North America dominated the global market in 2017. According to American Cancer Society’s Cancer Statistics, nearly 800 new cases of neuroblastoma are reported in the U.S. each year. This number has been stagnant for several years. Additionally, high cost of therapy, technologically advanced products, improved health care infrastructure, and better reimbursement plans are the major factors contributing to the region’s dominance of the global market. The market in Asia Pacific is projected to expand at a high CAGR during the forecast period owing to improving health care infrastructure and rise in public investment in research and technological advancements in countries such as China and India.
Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=37835
Major players operating in the global pediatric neuroblastoma treatment market are United Therapeutics Corporation, APEIRON Biologics AG, Baxter, Cellectar Biosciences, Inc., Pfizer, Inc., MacroGenics, Inc., and Bayer AG. These players are expanding their product portfolios through mergers and acquisitions and partnerships & collaborations with leading pharmaceutical and biotechnology companies, and by offering technologically advanced products.
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: amanpreet@tmr.com
Website: https://www.transparencymarketresearch.com/